| Primary |
| Breast Cancer |
46.6% |
| Drug Use For Unknown Indication |
26.3% |
| Breast Cancer Metastatic |
8.6% |
| Her-2 Positive Breast Cancer |
3.6% |
| Gastric Cancer |
3.4% |
| Product Used For Unknown Indication |
2.6% |
| Premedication |
1.3% |
| Pain |
1.0% |
| Hypertension |
0.9% |
| Nausea |
0.9% |
| Prophylaxis |
0.8% |
| Metastatic Gastric Cancer |
0.7% |
| Oesophageal Cancer Metastatic |
0.5% |
| Neoplasm Malignant |
0.5% |
| Diarrhoea |
0.4% |
| Transitional Cell Carcinoma |
0.4% |
| Oesophageal Adenocarcinoma |
0.4% |
| Constipation |
0.4% |
| Bladder Cancer |
0.3% |
| Cardiac Failure |
0.3% |
|
| Vomiting |
12.0% |
| Death |
10.6% |
| Pulmonary Embolism |
6.8% |
| Alanine Aminotransferase Increased |
6.5% |
| Pneumonia |
6.0% |
| Disease Progression |
5.5% |
| Thrombocytopenia |
5.5% |
| Sepsis |
5.3% |
| Syncope |
4.8% |
| Dehydration |
4.5% |
| Febrile Neutropenia |
4.3% |
| Myocardial Infarction |
3.9% |
| Neutropenia |
3.9% |
| Pyrexia |
3.9% |
| Chest Pain |
3.4% |
| Renal Failure |
2.7% |
| Atrial Fibrillation |
2.6% |
| Pancytopenia |
2.6% |
| Stomatitis |
2.6% |
| White Blood Cell Count Decreased |
2.6% |
|
| Secondary |
| Breast Cancer |
53.9% |
| Drug Use For Unknown Indication |
10.5% |
| Breast Cancer Metastatic |
7.6% |
| Her-2 Positive Breast Cancer |
7.0% |
| Product Used For Unknown Indication |
6.6% |
| Gastric Cancer |
2.1% |
| Lung Neoplasm Malignant |
1.4% |
| Hodgkin's Disease |
1.4% |
| Hypertension |
1.4% |
| Non-hodgkin's Lymphoma |
1.4% |
| Premedication |
1.0% |
| Prophylaxis |
1.0% |
| Malignant Breast Neoplasm |
0.9% |
| Chemotherapy |
0.9% |
| Nausea |
0.8% |
| Pain |
0.6% |
| Sarcoma |
0.5% |
| Invasive Ductal Breast Carcinoma |
0.4% |
| Osteosarcoma Metastatic |
0.4% |
| Depression |
0.4% |
|
| Vomiting |
15.4% |
| Pyrexia |
10.4% |
| Neutropenia |
8.8% |
| Febrile Neutropenia |
7.3% |
| Pneumonia |
6.1% |
| Death |
4.3% |
| Diarrhoea |
4.2% |
| Ejection Fraction Decreased |
4.0% |
| Myocardial Infarction |
3.8% |
| Pulmonary Embolism |
3.8% |
| Sepsis |
3.8% |
| Alanine Aminotransferase Increased |
3.4% |
| Disease Progression |
3.4% |
| Thrombocytopenia |
3.4% |
| Neutropenic Sepsis |
3.2% |
| Rash |
3.0% |
| Pleural Effusion |
2.9% |
| Syncope |
2.9% |
| White Blood Cell Count Decreased |
2.9% |
| Nausea |
2.8% |
|
| Concomitant |
| Breast Cancer |
47.4% |
| Metastases To Bone |
10.6% |
| Product Used For Unknown Indication |
6.1% |
| Premedication |
5.9% |
| Chemotherapy |
5.3% |
| Breast Cancer Metastatic |
5.0% |
| Her-2 Positive Breast Cancer |
3.5% |
| Pain |
2.8% |
| Prophylaxis |
2.6% |
| Breast Cancer Stage Iii |
1.6% |
| Drug Use For Unknown Indication |
1.1% |
| Osteoporosis |
1.1% |
| Sleep Apnoea Syndrome |
1.1% |
| Breast Cancer Recurrent |
1.0% |
| Osteopenia |
0.9% |
| Parkinson's Disease |
0.9% |
| Metastases To Liver |
0.9% |
| Breast Carcinoma Stage Iii |
0.8% |
| Depression |
0.8% |
| Neoplasm Malignant |
0.7% |
|
| Pyrexia |
9.5% |
| Wheezing |
9.0% |
| Dyspnoea |
8.0% |
| Weight Increased |
6.0% |
| Interstitial Lung Disease |
5.5% |
| Vomiting |
5.5% |
| Neutropenic Sepsis |
5.0% |
| Tooth Extraction |
5.0% |
| Wound Complication |
5.0% |
| Febrile Neutropenia |
4.5% |
| Helicobacter Infection |
4.5% |
| Cardiac Failure |
4.0% |
| Metastases To Liver |
4.0% |
| Thrombocytopenia |
4.0% |
| Disease Progression |
3.5% |
| Hypoaesthesia |
3.5% |
| Pneumonia |
3.5% |
| Rash |
3.5% |
| White Blood Cell Count Decreased |
3.5% |
| Diarrhoea |
3.0% |
|
| Interacting |
|
| Pancreatitis |
50.0% |
| Ventricular Dysfunction |
50.0% |
|
